Campbell & Co Investment Adviser’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,690
| Closed | -$369K | – | 1220 |
|
|
2024
Q3 | $369K | Hold |
3,690
| – | – | 0.03% | 827 |
|
|
2024
Q2 | $311K | Sell |
3,690
-1,071
| -22% | -$90.2K | 0.03% | 818 |
|
|
2024
Q1 | $348K | Sell |
4,761
-2,820
| -37% | -$206K | 0.03% | 847 |
|
|
2023
Q4 | $541K | Buy |
7,581
+2,435
| +47% | +$174K | 0.05% | 670 |
|
|
2023
Q3 | $308K | Buy |
5,146
+618
| +14% | +$37K | 0.04% | 704 |
|
|
2023
Q2 | $326K | Buy |
4,528
+151
| +3% | +$10.9K | 0.06% | 627 |
|
|
2023
Q1 | $322K | Sell |
4,377
-797
| -15% | -$58.6K | 0.06% | 579 |
|
|
2022
Q4 | $346K | Buy |
+5,174
| New | +$346K | 0.08% | 485 |
|
|
2019
Q1 | – | Sell |
-2,462
| Closed | -$231K | – | 563 |
|
|
2018
Q4 | $231K | Buy |
+2,462
| New | +$231K | 0.23% | 249 |
|
|
2018
Q2 | – | Sell |
-2,723
| Closed | -$281K | – | 459 |
|
|
2018
Q1 | $281K | Buy |
+2,723
| New | +$281K | 0.24% | 184 |
|